QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
NYSE:CIM

Chimera Investment (CIM) Stock Forecast, Price & News

$5.25
+0.03 (+0.57%)
(As of 06/7/2023 ET)
Compare
Today's Range
$5.20
▼
$5.32
50-Day Range
$4.54
▼
$5.68
52-Week Range
$4.48
▼
$10.66
Volume
1.96 million shs
Average Volume
1.98 million shs
Market Capitalization
$1.22 billion
P/E Ratio
N/A
Dividend Yield
17.52%
Price Target
$7.17
ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Chimera Investment MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
36.5% Upside
$7.17 Price Target
Short Interest
Bearish
4.58% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-3.09
Upright™ Environmental Score
News Sentiment
0.85mentions of Chimera Investment in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
19.23%
From $0.78 to $0.93 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.44 out of 5 stars

Finance Sector

380th out of 851 stocks

Real Estate Investment Trusts Industry

65th out of 189 stocks

See Top Rated MarketRank™ Stocks Here

CIM stock logo

About Chimera Investment (NYSE:CIM) Stock

Chimera Investment Corporation operates as an internally-managed real estate investment trust (REIT) in the United States. The company was incorporated in 2007 with the purpose of investing in mortgage loans, asset securitization, and mortgage-backed securities.

Chimere Investment Corporation is based in New York, New York, trades on the New York Stock Exchange, and works to provide attractive risk-adjusted returns via dividends and capital preservation. As of late 2022, the company had more than $3 billion in capitalization including common and preferred stock, and had paid more than $5.8 billion in dividends.

The company has elected to be taxed as a REIT which is a tax-sheltered vehicle for real estate investment. As such, the company must invest at least 75% of its assets in real estate and return 90% of its taxable income to shareholders in the form of dividends. The only drawback is that shareholders are responsible for income taxes on the earnings.

The company’s strategy is to invest in a portfolio of mortgage assets, including residential mortgage loans, agency, and non-agency residential mortgage-backed securities, and agency commercial mortgage-backed securities. Income is generated by the net spread between the income earned on investments and the costs of financing.

Chimera Investment Corporation finances its operations through secured pools of residential and commercial mortgage loans and by leveraging other real estate-related securities as well. The strategy not only provides a stable source of financing but also provides the flexibility to enhance returns or mitigate risk as necessary.

One risk of Chimera Investment Corporation is its exposure to US credit risk retention rules. These rules limit the company’s ability to sell or hedge a large portion of its RMBS portfolio which means it may have to hold some assets it would otherwise sell. In regard to portfolio diversification, RMBS historically make up about 11% of the portfolio while securitized loans comprise 80% to 90% of total holdings.

Chimera Investment Corporation investors may participate in a share repurchase plan as well. Investors of Record can participate directly in the plan while Beneficial Owners may request their shares be transferred to the agent of record and become Investors of Record.

Receive CIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chimera Investment and its competitors with MarketBeat's FREE daily newsletter.

CIM Stock News Headlines

May 16, 2023 | marketbeat.com
These 10%+ Yields are Mystery Meats – Avoid!
June 5, 2023 | technews.tmcnet.com
Chimera Announces Revised Ex-Dividend Date for Second Quarter Preferred Stock Cash Dividend - Payment Amount, Payable Date and Record Date Unchanged
June 7, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
June 5, 2023 | finance.yahoo.com
Chimera Announces Revised Ex-Dividend Date for Second Quarter Preferred Stock Cash Dividend – Payment Amount, Payable Date and Record Date Unchanged
June 2, 2023 | msn.com
Chimera Investment Corp Cum Red Pfd Registered Series A declares $0.50 dividend
June 1, 2023 | finance.yahoo.com
Chimera Declares Second Quarter 2023 Preferred Stock Dividends
May 26, 2023 | americanbankingnews.com
Chimera Investment (NYSE:CIM) Reaches New 12-Month Low at $4.75
May 22, 2023 | americanbankingnews.com
Credit Suisse Group Cuts Chimera Investment (NYSE:CIM) Price Target to $5.50
June 7, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
May 20, 2023 | americanbankingnews.com
Chimera Investment (NYSE:CIM) Now Covered by StockNews.com
May 19, 2023 | msn.com
Credit Suisse Maintains Chimera Investment (CIM) Neutral Recommendation
May 18, 2023 | americanbankingnews.com
Chimera Investment (NYSE:CIM) Reaches New 12-Month Low at $4.85
May 17, 2023 | msn.com
RBC Capital Maintains Chimera Investment (CIM) Outperform Recommendation
May 17, 2023 | markets.businessinsider.com
What 5 Analyst Ratings Have To Say About Chimera Investment
May 17, 2023 | americanbankingnews.com
Short Interest in Chimera Investment Co. (NYSE:CIM) Expands By 7.5%
May 17, 2023 | americanbankingnews.com
Short Interest in Chimera Investment Co. (NYSE:CIM) Rises By 7.5%
May 14, 2023 | fool.com
Chimera Investment Corporation (NYSE: CIM)
May 9, 2023 | markets.businessinsider.com
Chimera Investment (CIM) Receives a Rating Update from a Top Analyst
May 4, 2023 | wsj.com
Chimera Investment Corp. 8% Cum. Redeem. Pfd. Series A
May 4, 2023 | finance.yahoo.com
Q1 2023 Chimera Investment Corp Earnings Call
May 4, 2023 | markets.businessinsider.com
Chimera Investment Corp. Q1 Earnings Summary
May 4, 2023 | msn.com
Chimera Investment: Q1 Earnings Insights
May 4, 2023 | msn.com
Chimera Investment Q1 earnings fall short as net interest income dives
May 4, 2023 | finance.yahoo.com
Chimera Investment (CIM) Q1 Earnings and Revenues Lag Estimates
May 4, 2023 | markets.businessinsider.com
Chimera Investment earnings: here's what Wall Street expects
May 4, 2023 | finance.yahoo.com
CHIMERA INVESTMENT CORPORATION REPORTS 1ST QUARTER 2023 EARNINGS
May 3, 2023 | americanbankingnews.com
Chimera Investment (CIM) to Release Quarterly Earnings on Thursday
See More Headlines

CIM Price History

CIM Company Calendar

Ex-Dividend for 4/27 Dividend
3/30/2023
Dividend Payable
4/27/2023
Last Earnings
5/04/2023
Today
6/07/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Real estate investment trusts
Sub-Industry
Mortgage REITs
Sector
Finance
Current Symbol
NYSE:CIM
CUSIP
16934Q10
CIK
1409493
Web
www.chimerareit.com
Phone
(888) 895-6557
Fax
212-696-9809
Employees
38
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.17
High Stock Price Forecast
$9.00
Low Stock Price Forecast
$5.50
Forecasted Upside/Downside
+36.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($1.13)
Trailing P/E Ratio
N/A
Forward P/E Ratio
6.73
P/E Growth
N/A
Net Income
$-513,070,000.00
Net Margins
-25.38%
Pretax Margin
-25.40%
Return on Equity
9.79%
Return on Assets
1.94%

Debt

Debt-to-Equity Ratio
2.86
Current Ratio
0.09
Quick Ratio
0.09

Sales & Book Value

Annual Sales
$773.12 million
Price / Sales
1.58
Cash Flow
$1.74 per share
Price / Cash Flow
3.01
Book Value
$11.51 per share
Price / Book
0.46

Miscellaneous

Outstanding Shares
232,100,000
Free Float
230,378,000
Market Cap
$1.22 billion
Optionable
Optionable
Beta
1.52

Key Executives

  • Phillip John Kardis
    Chief Executive Officer & Director
  • Choudhary Yarlagadda
    President, Chief Operating Officer & Co-CIO
  • Subramaniam Viswanathan
    Chief Financial Officer
  • Dan Sudhanshu Thakkar
    Co-Chief Investment Officer
  • Kelley Kortman
    Chief Accounting Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













CIM Stock - Frequently Asked Questions

Should I buy or sell Chimera Investment stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Chimera Investment in the last twelve months. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CIM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CIM, but not buy additional shares or sell existing shares.
View CIM analyst ratings or view top-rated stocks.

What is Chimera Investment's stock price forecast for 2023?

3 brokers have issued 1 year price objectives for Chimera Investment's shares. Their CIM share price forecasts range from $5.50 to $9.00. On average, they predict the company's stock price to reach $7.17 in the next year. This suggests a possible upside of 36.5% from the stock's current price.
View analysts price targets for CIM or view top-rated stocks among Wall Street analysts.

How have CIM shares performed in 2023?

Chimera Investment's stock was trading at $5.50 at the beginning of 2023. Since then, CIM shares have decreased by 4.5% and is now trading at $5.25.
View the best growth stocks for 2023 here.

Are investors shorting Chimera Investment?

Chimera Investment saw a increase in short interest in April. As of April 30th, there was short interest totaling 9,630,000 shares, an increase of 7.5% from the April 15th total of 8,960,000 shares. Based on an average trading volume of 2,020,000 shares, the short-interest ratio is currently 4.8 days. Currently, 4.2% of the shares of the company are short sold.
View Chimera Investment's Short Interest.

When is Chimera Investment's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our CIM earnings forecast.

How were Chimera Investment's earnings last quarter?

Chimera Investment Co. (NYSE:CIM) announced its quarterly earnings results on Thursday, May, 4th. The real estate investment trust reported $0.13 EPS for the quarter, missing the consensus estimate of $0.16 by $0.03. The real estate investment trust earned $189.25 million during the quarter, compared to analyst estimates of $86.60 million. Chimera Investment had a positive trailing twelve-month return on equity of 9.79% and a negative net margin of 25.38%. During the same period last year, the business earned $0.39 earnings per share.

How often does Chimera Investment pay dividends? What is the dividend yield for Chimera Investment?

Chimera Investment announced a quarterly dividend on Thursday, February 2nd. Investors of record on Friday, March 31st will be given a dividend of $0.23 per share on Thursday, April 27th. This represents a $0.92 dividend on an annualized basis and a yield of 17.52%. The ex-dividend date of this dividend is Thursday, March 30th.
Read our dividend analysis for CIM.

What ETFs hold Chimera Investment's stock?

ETFs with the largest weight of Chimera Investment (NYSE:CIM) stock in their portfolio include VanEck Mortgage REIT Income ETF (MORT), Invesco KBW High Dividend Yield Financial ETF (KBWD), iShares Mortgage Real Estate ETF (REM), WisdomTree Alternative Income Fund (HYIN), Hoya Capital High Dividend Yield ETF (RIET), Global X SuperDividend ETF (SDIV), GraniteShares HIPS US High Income ETF (HIPS) and Hoya Capital Housing ETF (HOMZ).

Is Chimera Investment a good dividend stock?

Chimera Investment (NYSE:CIM) pays an annual dividend of $0.92 per share and currently has a dividend yield of 18.15%. CIM has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for CIM.

What is Matthew Lambiase's approval rating as Chimera Investment's CEO?

3 employees have rated Chimera Investment Chief Executive Officer Matthew Lambiase on Glassdoor.com. Matthew Lambiase has an approval rating of 100% among the company's employees. This puts Matthew Lambiase in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Chimera Investment own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chimera Investment investors own include New Residential Investment (NRZ), Annaly Capital Management (NLY), Marathon Oil (MRO), AGNC Investment (AGNC), Energy Transfer (ET), AT&T (T), ARMOUR Residential REIT (ARR), New York Mortgage Trust (NYMT), Enterprise Products Partners (EPD) and NGL Energy Partners (NGL).

What is Chimera Investment's stock symbol?

Chimera Investment trades on the New York Stock Exchange (NYSE) under the ticker symbol "CIM."

Who are Chimera Investment's major shareholders?

Chimera Investment's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (8.43%), Thornburg Investment Management Inc. (7.38%), State Street Corp (2.39%), Geode Capital Management LLC (1.91%), Leeward Investments LLC MA (1.34%) and Charles Schwab Investment Management Inc. (0.95%).
View institutional ownership trends.

How do I buy shares of Chimera Investment?

Shares of CIM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chimera Investment's stock price today?

One share of CIM stock can currently be purchased for approximately $5.25.

How much money does Chimera Investment make?

Chimera Investment (NYSE:CIM) has a market capitalization of $1.22 billion and generates $773.12 million in revenue each year. The real estate investment trust earns $-513,070,000.00 in net income (profit) each year or ($1.13) on an earnings per share basis.

How can I contact Chimera Investment?

Chimera Investment's mailing address is 520 MADISON AVENUE 32ND FLOOR, NEW YORK NY, 10022. The official website for the company is www.chimerareit.com. The real estate investment trust can be reached via phone at (888) 895-6557, via email at investor@chimerareit.com, or via fax at 212-696-9809.

This page (NYSE:CIM) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -